维普期刊资源整合服务平台（V6.5）

98篇 您的检索式：作者名="Bennett MW"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Immune privilege or inflammation? Insights into the Fas ligand enigma显示文摘	O'Connell J Houston A Bennett MW	2001	Nat Med2001，7，3：	1
2	The fas counterattack in vivo:apoptotic depletion of tumor 2 infiltrating lymphocytes associated with fas ligand expression by human esophageal carcinoma显示文摘	O CONNELL J O SULLIVAN GC	1997	J clin Invest1997，99，：	1
3	Expression of Fas ligand by human gastric adenocarcinoma:a potential mechanism of immune escape in stomach cancer显示文摘	Bennett MW O'Connel J O'Sullivan GC	1999	Gut1999，44，2：	1
4	Specific binding of human low-density lipoprotein to the surface of sehistosomula of Sehistosoma mansoni and ingestion by the parasite显示文摘	Bennett MW and Caulfield J P	1991	Am J Pathol1991，138，5：	1
5	Immune privilege or inflammation? Insights into the Fas ligand enigma 显示文摘	Houston A Bennett MW	2001	Nature Med2001，7，3：	1
6	Expression of Fas ligand by human gastric adenocarcinomas:a potential mechanism of immune escape in stomach cancer显示文摘	Bennett MW O Connel J O Sullivan GC	1999	Gut1999，44，：	1
7	Fas ligand expression in primary colon adenocarcinomas:evidence that the Fas counter attack is a prevalent mechanism of immune evasion in human colon cancer显示文摘	O' Connell J Bennett MW O' Sullivan GC	1998	J Pathol1998，186，1：	1
8	PCR detection of mycobacterium paratuberculosis in Crohn s disease granulomas isolated by laser capture microdissection 显示文摘	Ryan P Bennett MW Aarons S	2002	Gut2002，51，5：	1
9	Upregulation of Fas - FasL( CD95/CD95L) - mediated epithelial apoptosis显示文摘	Coffey JC Bennett MW Wang JH	2001	A putative role in pouchitis? J Surg Res2001，98，1：	1
10	The Fas counterattack: Cancer as a site of immune privilege 显示文摘	Bennett MW O' Sullivan GC	1999	Immunol Today1999，20，1：	1
11	The Fas counter-attack in vivo apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas Ligand expression by human esophageal carcinoma 显示文摘	Bennett MW O' Coneell O' Sullivan	1998	J I mmunol1998，160，：	1
12	Expressionof Fas ligand by human gastric adenocarcinomas:a potential mechanism of immune escape in smmach cancer显示文摘	Bennett Mw O'connell J O'sullivan GC	2000	Gut2000，46，5：	1
13	Altered mechanisms of apoptosis in colon cancer: Fas resitance and counterattack in tumor-immune conflict显示文摘	O' Coneell J Michael W Bennett MW	2000	Ann NY Acad sci2000，910，：	1
14	The Fas counterattack in vivo apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas Ligand expression by human esophageal carcinoma显示文摘	Bennett MW O' Connel J O' Sullivan GC	1998	J Immunol1998，160，：	1
15	Microcystic/reticular schwannoma:a distinct variant with predilection for visceral locations显示文摘	Liegl B Bennett MW Fletcher CD	2008	Am J Surg Pathol2008，32，7：	1
16	Expression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege显示文摘	O′connell J Bennett MW O′sulivan GC	1999	Clin Diagn Lab Immunol1999，6，：	1
17	Expression of Fas ( CD95/APO21 ) ligand by human gastric adenocarcinomas:a potential mechanismof immune escape in stomach cancer 显示文摘	O' Connel J Bennett MW O' Sullivan GC	1999	Gut1999，44，：	1
18	Expression of Fas ligand by human gastric adenocarcinomas:a potential mechanism of immune escape in stomach cancer显示文摘	Bennett MW O'Connell J O'Sullivan GC	1999	Gut1999，44，：	1
19	Fas ligand and Fas receptor are coexpressed in normal human esophageal epithelium:a potential mechanism of apoptotic epithelial turnover 显示文摘	O' Connell J O'Sullivan GC	1999	DisEsophagus1999，12，2：	1
20	The Fas counterattack:cancer as a site of immune privilege显示文摘	Bennett MW O′Sullivan GC	1999	Immunology Today1999，20，1：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示